Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11—first estimates for clinical translation

Por Kaloudi, Aikaterini, Nock, Berthold A., Lymperis, Emmanouil, Valkema, Roelf, Krenning, Eric P., de Jong, Marion, Maina, Theodosia
Publicado no EJNMMI Res (2016)

[(111)In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

Por Tatsi, Aikaterini, Maina, Theodosia, Cescato, Renzo, Waser, Beatrice, Krenning, Eric P, de Jong, Marion, Cordopatis, Paul, Reubi, Jean Claude, Nock, Berthold A
Publicado em 2012

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

Por Fröberg, Alida C., de Jong, Marion, Nock, Berthold A., Breeman, Wout A. P., Erion, Jack L., Maina, Theodosia, Verdijsseldonck, Marion, de Herder, Wouter W., van der Lugt, Aad, Kooij, Peter P. M., Krenning, Eric P.
Publicado em 2009

Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary...

Por Maina, Theodosia, Konijnenberg, Mark W., KolencPeitl, Petra, Garnuszek, Piotr, Nock, Berthold A., Kaloudi, Aikaterini, Kroselj, Marko, Zaletel, Katja, Maecke, Helmut, Mansi, Rosalba, Erba, Paola, von Guggenberg, Elisabeth, Hubalewska-Dydejczyk, Alicja, Mikolajczak, Renata, Decristoforo, Clemens
Publicado no Eur J Pharm Sci (2016)

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

Por Chatalic, Kristell L.S., Konijnenberg, Mark, Nonnekens, Julie, de Blois, Erik, Hoeben, Sander, de Ridder, Corrina, Brunel, Luc, Fehrentz, Jean-Alain, Martinez, Jean, van Gent, Dik C., Nock, Berthold A., Maina, Theodosia, van Weerden, Wytske M., de Jong, Marion
Publicado no Theranostics (2016)